The CD13 antigen is present on most cells of myeloid origin, including granulocytes and monocytes in normal peripheral blood. CD13 is not expressed on B-cells, T-cells, platelets or erythrocytes. Expression of this antigen is greater on monocytes than on granulocytes.
Applications
Suitable for use in Flow Cytometry, Direct ELISA, Western Blot and Immunoprecipitation. Other applications not tested.
Recommended Dilutions
Flow Cytometry: 25ug/ml. Use 10ul to label 1-2.5x10e5 cells in total reaction volume ≤200ul. Tested for use using U937 cells. Direct ELISA: 0.5-1.0ug/ml. The detection limit for recombinant human CD13 is ~0.3ng/well. Western Blot: 0.1-0.2ug/ml. The detection limit for recombinant human CD13 is ~5ng/lane under non-reducing and reducing conditions. Immunoprecipitation: Precipitates CD13 from conditioned media of transfected NSO cells. KO Validated: Aminopeptidase N/CD13 is specifically detected in U937 human histiocytic lymphoma parental cell line but is not detectable in Aminopeptidase N/CD13 knockout U937 human histiocytic lymphoma cell line. Optimal dilutions to be determined by the researcher.
Storage and Stability
Lyophilized and reconstituted products are stable for 12 months after receipt at -20°C. Reconstitute with sterile PBS. Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
Immunogen
Recombinant protein corresponding to Lys69-Lys967 from human CD13 expressed in NSO cells.
Form
Supplied as a lyophilized powder from PBS, 5% trehalose. Reconstitute with 500ul sterile PBS.
Purity
Purified by immunoaffinity chromatography.
Specificity
Recognizes human CD13. Weakly crossreacts (20%) with recombinant mouse CD13 in ELISA and Western Blot.